Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27221
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJantaharn P.
dc.contributor.authorMongkolthanaruk W.
dc.contributor.authorSuwannasai N.
dc.contributor.authorSenawong T.
dc.contributor.authorBoonmak J.
dc.contributor.authorYoungme S.
dc.contributor.authorMcCloskey S.
dc.date.accessioned2022-12-14T03:17:00Z-
dc.date.available2022-12-14T03:17:00Z-
dc.date.issued2022
dc.identifier.issn14786419
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85138435010&doi=10.1080%2f14786419.2022.2125968&partnerID=40&md5=b5dc24d5493ceff46b7aed645feb0489
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/27221-
dc.description.abstractA new oxa-bridged seven-membered ring analog, hypoxylonone (1), and thirteen known compounds (2–14) were isolated from fungus Hypoxylon cf. subgilvum SWUF15-004. The structures were elucidated by the analysis of spectroscopic (IR, 1 D and 2 D NMR), HRESIMS and X-ray diffraction (MoKα) data. Several isolated compounds were evaluated for cytotoxicity against four human cancer cell lines (HeLa, HT29, MCF-7, A549). Compound 1 exhibited weak inhibitory effects of the nitric oxide production in RAW264.7 cells. Compounds 8 and 9 exhibited slight cytotoxicity. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
dc.languageen
dc.publisherTaylor and Francis Ltd.
dc.subject8-oxabicyclo[3.2.1]octane
dc.subjectcytotoxicity
dc.subjectHypoxylon cf. subgilvum
dc.subjectoxa-bridged seven-membered ring
dc.titleHypoxylonone, a new oxa-bridged seven-membered ring analog from fungus Hypoxylon cf. subgilvum SWUF15-004
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationKasetsart Journal of Social Sciences. Vol 43, No.4 (2022), p.1085-1094
dc.identifier.doi10.1080/14786419.2022.2125968
Appears in Collections:Scopus 2022

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.